Santos, Tírcia C <br/><br/>
Vascular endothelial growth factor and fibroblast growth factor-2 incorporation in starch-based bone tissue-engineered constructs promote the in vivo expression of neovascularization mediators.  [electronic resource] 

 -  Tissue engineering. Part A  Apr 2013 
 - 834-48 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1937-335X 
<br/><br/><label>Standard No.: </label>10.1089/ten.TEA.2010.0741  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Bone and Bones--drug effects<br/>Cell Tracking<br/>Female<br/>Fibroblast Growth Factor 2--pharmacology<br/>Humans<br/>Luminescent Measurements<br/>Mice<br/>Mice, Nude<br/>Mice, Transgenic<br/>Microvessels--drug effects<br/>Middle Aged<br/>Neovascularization, Physiologic--drug effects<br/>Polyesters--pharmacology<br/>Starch--pharmacology<br/>Tissue Engineering<br/>Tissue Scaffolds--chemistry<br/>Vascular Endothelial Growth Factor A--pharmacology<br/>Vascular Endothelial Growth Factor Receptor-2--metabolism